Kidney patients needed to test new infection drug
NCT ID NCT06522945
First seen Jan 10, 2026 · Last updated Jun 08, 2026 · Updated 20 times
Summary
This study looked at how the body processes a new antibiotic called TQD3524 in people with different levels of kidney function. 48 adults with kidney problems received a single dose to measure drug levels and safety. The goal was to understand dosing, not to treat the infection directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI-RESISTANT GRAM-NEGATIVE BACTERIA CAUSE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.